Normal view MARC view ISBD view

Vandetanib: in medullary thyroid cancer.

Frampton, James E

Vandetanib: in medullary thyroid cancer. [electronic resource] - Drugs Jul 2012 - 1423-36 p. digital

Publication Type: Journal Article; Review

ISSN: 1179-1950

Standard No.: 10.2165/11209300-000000000-00000 doi

Subjects--Topical Terms:
Administration, Oral
Antineoplastic Agents--administration & dosage
Carcinoma, Neuroendocrine
Disease-Free Survival
Humans
Molecular Structure
Neoplasm Metastasis
Piperidines--administration & dosage
Protein-Tyrosine Kinases--antagonists & inhibitors
Quinazolines--administration & dosage
Randomized Controlled Trials as Topic
Thyroid Neoplasms--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)